WHO ICTRP trial

Chemotherapy-induced alopecia (CIA) in breast cancer patients: effectiveness of…

ACTRN12615001106527 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12615001106527
Public title Chemotherapy-induced alopecia (CIA) in breast cancer patients: effectiveness of two temperature levels of scalp cooling on reducing rates of CIA.
Scientific title Incidence of chemotherapy-induced alopecia (CIA) in breast cancer patients": effectiveness of two temperature levels of scalp cooling on reducing incidence of CIA
Primary sponsor Breast Cancer Research Centre of Western Australia
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Not Applicable
Countries Australia
Conditions chemotherapy-induced alopecia;breast cancer; chemotherapy-induced alopecia breast cancer;Cancer - Breast
Interventions scalp-cooling treatment:patient wears a cap which is connected to a refrigerated cooling system which pumps liquid coolant through the cap to keep the scalp cool and blood vessels constricted to minimise chemotherapy delivery to hair…
Registration date Oct 21, 2015
Target size 60
Secondary IDs BCRC113
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations